Volume 105, Issue 5 , Pages 399-403, 2006
Clinical Improvement Following Home Parenteral Nutrition in Pediatric Patients with Intestinal Failure
Article Outline
Background/Purpose
Home parenteral nutrition (HPN) is being increasingly used to treat children with intestinal failure. This study evaluated the long-term growth, outcome and complications in Taiwanese pediatric patients with intestinal failure who were treated with HPN.
Methods
This retrospective study included 27 consecutive pediatric patients with intestinal failure who received long-term HPN between 1987 and 2002. These patients were categorized into two groups according to whether they had short bowel syndrome or a bowel motility disorder. Growth, prognosis and complications, including cholestasis, hypoglycemia, hyperglycemia and infections were compared between the two groups.
Results
The median age of starting HPN was significantly younger in patients with short bowel syndrome (5 months) than in patients with motility disorders (1.9 years). The median duration of HPN treatment in the overall group was 13.5 months (range, 2.1-113.1 months); weight and height increased 1.7 ± 2.3 and 1.0 ± 1.6 in z score, respectively. The most common complications were cholestatic liver disease (52%), hypoglycemia (15%) and hyperglycemia (33%). All patients maintained stable serum glucose levels at follow-up. Cholestatic liver disease developed after 2.3 ± 2.0 months of total HPN in 13 patients, which subsided after 9.7 ± 6.9 months in 11 patients, while two patients died. The mean incidence of central venous infection was 3.0 ± 3.3 per 1000 HPN days. The most common pathogens were Staphylococcus spp. (50%) and Candida spp. (30.6%).
Conclusion
HPN treatment can successfully provide a bridge to enteral nutrition in pediatric patients with intestinal failure. The metabolic disturbances and cholestasis are usually transient, but infection control is important throughout the period of HPN treatment.
Key Words: bacteremia , bowel motility disorder , cholestatic liver disease , home parenteral nutrition , short bowel syndrome
No full text is available. To read the body of this article, please view the PDF online.
References
- . Nutrition and the Surgical Patient: Intestinal Failure . In: Hill GL editors. Clinical Surgery International . Edinburgh: Churchill Livingstone; 1981;p. 219–235
- Long term par-enteral nutrition through external arteriovenous shunt . N Engl J Med. . 1970;283:341–344
- . Management of complications in patients receiving home parenteral nutrition . Gastroenter-ology . 2003;124:1651–1661
- . Management of gut failure: a physician's view . Lancet . 1994;344:1061–1064
- . An international perspective on artificial nutritional support in the community . Lancet . 1995;345:1345–1349
- Outcome and quality of life in paediatric home parenteral nutrition . Curr Opin Clin Nutr Metab Care . 2002;5:309–314
- . Nutritional support at home and in the community . Arch Dis Child . 2001;84:295–298
- . Intestinal failure . J Gastroenterol Hepat . 2000;15:26–29
- . Home parenteral nutrition. 25 years later . Gastroenterol Clin North Am. . 1998;27:481–512
- Central venous catheter complications in 447 patients on home parenteral nutrition: an analysis of over 100000 catheter days . Clin Nutr . 2002;21:475–485
- Central venous catheter-related infections in children on long-term home parenteral nutrition: incidence and risk factors . Clin Nutr . 2000;19:355–359
- Home parenteral nutrition: does affiliation with a national support and educational organization improve patient outcomes? . J Parenter Enteral Nutr . 2002;26:159–163
- Catheter-related infection in patients on parenteral nutrition: results of a prospective survey . Clin Nutr . 2002;21:33–38
- Prevention and treatment of implanted central venous catheter-related sepsis: a report after six years of home parenteral nutrition . Clin Nutr . 2002;21:207–211
- Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure . Ann Intern Med. . 2000;132:525–532
PII: S0929-6646(09)60136-4
doi:10.1016/S0929-6646(09)60136-4
© 2006 Formosan Medical Association & Elsevier. Published by Elsevier Inc. All rights reserved.
Volume 105, Issue 5 , Pages 399-403, 2006
